1.14
Rockwell Medical Inc stock is traded at $1.14, with a volume of 319.25K.
It is down -1.30% in the last 24 hours and up +0.88% over the past month.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
See More
Previous Close:
$1.155
Open:
$1.16
24h Volume:
319.25K
Relative Volume:
1.19
Market Cap:
$39.25M
Revenue:
$98.92M
Net Income/Loss:
$-1.24M
P/E Ratio:
-19.00
EPS:
-0.06
Net Cash Flow:
$2.64M
1W Performance:
+11.76%
1M Performance:
+0.88%
6M Performance:
-35.59%
1Y Performance:
-61.49%
Rockwell Medical Inc Stock (RMTI) Company Profile
Name
Rockwell Medical Inc
Sector
Phone
(800) 449-3353
Address
30142 WIXOM ROAD, WIXOM, NJ
Compare RMTI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
RMTI
Rockwell Medical Inc
|
1.14 | 36.15M | 98.92M | -1.24M | 2.64M | -0.06 |
![]()
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Rockwell Medical Inc Stock (RMTI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
Jun-24-19 | Initiated | Piper Jaffray | Overweight |
May-13-19 | Initiated | H.C. Wainwright | Buy |
Nov-08-16 | Downgrade | BofA/Merrill | Neutral → Underperform |
Mar-01-16 | Downgrade | Stifel | Buy → Hold |
Aug-13-15 | Initiated | Morgan Stanley | Underweight |
Jan-27-15 | Reiterated | Oppenheimer | Outperform |
Jan-07-15 | Initiated | Oppenheimer | Outperform |
Aug-14-14 | Initiated | FBR Capital | Underperform |
Dec-19-13 | Initiated | Chardan Capital Markets | Buy |
Nov-06-13 | Reiterated | Summer Street Research | Buy |
Sep-05-13 | Reiterated | Summer Street Research | Buy |
Aug-02-13 | Reiterated | Summer Street Research | Buy |
Apr-11-12 | Initiated | Summer Street Research | Buy |
Mar-12-12 | Initiated | Stifel Nicolaus | Buy |
Jan-03-12 | Initiated | Canaccord Genuity | Buy |
Dec-10-09 | Initiated | JMP Securities | Mkt Outperform |
Oct-12-09 | Initiated | Wedbush Morgan | Outperform |
View All
Rockwell Medical Inc Stock (RMTI) Latest News
Key metrics from Rockwell Medical Inc.’s quarterly dataJuly 2025 Drop Watch & Weekly Setup with High ROI Potential - Newser
Real time scanner hits for Rockwell Medical Inc. explained2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - Newser
Order flow analysis tools used on Rockwell Medical Inc.2025 Analyst Calls & Safe Entry Point Identification - Newser
Applying big data sentiment scoring on Rockwell Medical Inc.Portfolio Update Summary & Smart Investment Allocation Insights - Newser
Combining machine learning predictions for Rockwell Medical Inc.Jobs Report & Verified Chart Pattern Signals - Newser
Rockwell Medical Inc.’s Beta Climbs After Market VolatilityWeekly Profit Recap & Entry Point Confirmation Signals - classian.co.kr
Chart based exit strategy for Rockwell Medical Inc.Portfolio Gains Report & Comprehensive Market Scan Reports - Newser
Is now a turning point for Rockwell Medical Inc.Portfolio Update Report & Free Expert Verified Stock Movement Alerts - Newser
Using AI based signals to follow Rockwell Medical Inc.July 2025 Opening Moves & Expert Verified Stock Movement Alerts - Newser
Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Could Be 34% Below Their Intrinsic Value Estimate - simplywall.st
Is Rockwell Medical Inc. stock poised for growthWeekly Risk Report & Capital Efficiency Focused Strategies - Newser
Using portfolio simulators with Rockwell Medical Inc. includedBull Run & Low Drawdown Trading Techniques - Newser
Rockwell Medical’s Growth Potential and Stability: A Buy Rating by Ram Selvaraju - TipRanks
Trend analysis for Rockwell Medical Inc. this weekCEO Change & Verified Technical Signals - Newser
Rockwell Medical Posts Q2 Loss Amid Weak Operating Performance—Market Reaction Signals Heightened Sensitivity - AInvest
Using Bollinger Bands to evaluate Rockwell Medical Inc.Chart Signals & Free Fast Gain Swing Trade Alerts - Newser
What institutional flow reveals about Rockwell Medical Inc.Market Sentiment Summary & Long-Term Safe Investment Ideas - Newser
Live market analysis of Rockwell Medical Inc.Weekly Risk Report & Verified Entry Point Signals - Newser
Rockwell Medical Posts Second Earnings Miss in Q2 2025 Amid Rising Costs — Market Reacts Poorly - AInvest
Can trapped investors hope for a rebound in Rockwell Medical Inc.Portfolio Performance Report & Reliable Entry Point Trade Alerts - Newser
Rockwell Medical reiterates $65M-$70M sales target for 2025 as new contracts expand long-term revenue base - MSN
Is it time to cut losses on Rockwell Medical Inc.2025 Market Trends & Community Supported Trade Ideas - Newser
Rockwell Medical's Strategic Positioning and Growth Potential Justifies Buy Rating, Says Analyst Anthony Vendetti. - AInvest
How institutional ownership impacts Rockwell Medical Inc. stockJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - Newser
Applying Elliott Wave Theory to Rockwell Medical Inc.July 2025 Outlook & Daily Chart Pattern Signals - Newser
What’s the recovery path for long term holders of Rockwell Medical Inc.Share Buyback & Free Daily Entry Point Trade Alerts - Newser
Will Rockwell Medical Inc. rebound enough to break evenWeekly Gains Summary & Fast Exit and Entry Trade Guides - Newser
Rockwell Medical: Strategic Positioning and Growth Potential Justify Buy Rating - TipRanks
Rockwell Medical, Inc. (NASDAQ:RMTI) Q2 2025 Earnings Call Transcript - Insider Monkey
Rockwell Medical Q2 2025 Earnings: Revenue Down 38% - AInvest
Rockwell Medical 2025 Q2 Earnings Significant Loss as Net Income Plummets 535% - AInvest
Rockwell Medical: Q2 Earnings Snapshot - Norwalk Hour
Rockwell Medical Reports Q2 2025 Financial Results - TipRanks
Rockwell Medical Inc Stock (RMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Rockwell Medical Inc Stock (RMTI) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Neri Jesse | SVP and CFO |
Jul 01 '25 |
Sale |
0.82 |
886 |
727 |
126,614 |
Strobeck Mark | President and CEO |
Jul 01 '25 |
Sale |
0.82 |
6,926 |
5,679 |
337,752 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):